Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

B Geoerger; JW Chisholm; MC le Deley; JC Gentet; C.M. Zwaan; N Dias; T Jaspan; K Mc Hugh; D Couanet; S Hain; Annick Devos; R Riccardi; C Cesare; J Boos; D Frappaz; P Leblond; I Aerts; G Vassal

doi:10.1016/j.ejca.2010.09.015

Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

B Geoerger, JW Chisholm, MC le Deley, JC Gentet, C.M. Zwaan, N Dias, T Jaspan, K Mc Hugh, D Couanet, S Hain, Annick Devos, R Riccardi, C Cesare, J Boos, D Frappaz, P Leblond, I Aerts, G Vassal

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	230-238
Number of pages	9
Journal	European Journal of Cancer
Volume	47
DOIs	https://doi.org/10.1016/j.ejca.2010.09.015
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2010.09.015

http://hdl.handle.net/1765/34101

Cite this

Geoerger, B., Chisholm, JW., le Deley, MC., Gentet, JC., Zwaan, C. M., Dias, N., Jaspan, T., Mc Hugh, K., Couanet, D., Hain, S., Devos, A., Riccardi, R., Cesare, C., Boos, J., Frappaz, D., Leblond, P., Aerts, I., & Vassal, G. (2011). Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. European Journal of Cancer, 47, 230-238. https://doi.org/10.1016/j.ejca.2010.09.015

@article{f3a826302ba64d8bbbb6b64c56440eb4,

title = "Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study",

author = "B Geoerger and JW Chisholm and {le Deley}, MC and JC Gentet and C.M. Zwaan and N Dias and T Jaspan and {Mc Hugh}, K and D Couanet and S Hain and Annick Devos and R Riccardi and C Cesare and J Boos and D Frappaz and P Leblond and I Aerts and G Vassal",

year = "2011",

doi = "10.1016/j.ejca.2010.09.015",

language = "Undefined/Unknown",

volume = "47",

pages = "230--238",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Geoerger, B, Chisholm, JW, le Deley, MC, Gentet, JC, Zwaan, CM, Dias, N, Jaspan, T, Mc Hugh, K, Couanet, D, Hain, S, Devos, A, Riccardi, R, Cesare, C, Boos, J, Frappaz, D, Leblond, P, Aerts, I & Vassal, G 2011, 'Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study', European Journal of Cancer, vol. 47, pp. 230-238. https://doi.org/10.1016/j.ejca.2010.09.015

Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. / Geoerger, B; Chisholm, JW; le Deley, MC et al.

In: European Journal of Cancer, Vol. 47, 2011, p. 230-238.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase II study of gemcitabine combined with oxaloplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

AU - Geoerger, B

AU - Chisholm, JW

AU - le Deley, MC

AU - Gentet, JC

AU - Zwaan, C.M.

AU - Dias, N

AU - Jaspan, T

AU - Mc Hugh, K

AU - Couanet, D

AU - Hain, S

AU - Devos, Annick

AU - Riccardi, R

AU - Cesare, C

AU - Boos, J

AU - Frappaz, D

AU - Leblond, P

AU - Aerts, I

AU - Vassal, G

PY - 2011

Y1 - 2011

U2 - 10.1016/j.ejca.2010.09.015

DO - 10.1016/j.ejca.2010.09.015

M3 - Article

VL - 47

SP - 230

EP - 238

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -